"Dermatologist tested" and "hypoallergenic" are marketing phrases, not certifications: no federal agency defines either term, checks the testing behind it, or requires proof before a product ships. The Food and Drug Administration says so plainly in its own guidance on cosmetic labeling. A brand can print either phrase on a bottle without ever submitting a test result to anyone, which means the label is doing marketing work, not disclosure work — and figuring out what was actually tested is left to you.
Does "hypoallergenic" mean a dermatologist checked it for allergic reactions?
Not in any enforceable sense. The FDA defines hypoallergenic cosmetics as products for which "manufacturers claim" fewer allergic reactions than competing products — the agency's own word is "claim," not "prove." Its guidance states outright that "there are no Federal standards or definitions that govern the use of the term 'hypoallergenic,'" so each company decides what qualifies.
That gap isn't an oversight. A federal court struck down the FDA's attempt to require testing behind hypoallergenic claims back in the 1970s, ruling the agency's definition of the term was unreasonable. Manufacturers have been free to use the word without supporting evidence ever since, and the FDA's current consumer guidance confirms manufacturers "are not required to submit substantiation of their hypoallergenicity claims to FDA." The same guidance adds a blunt aside worth remembering at the shelf: while the word has "considerable market value in promoting cosmetic products," the agency notes that "dermatologists say it has very little meaning."
Who actually checks a beauty claim before it reaches shelves?
No one, in advance. The FDA's cosmetic-labeling rules require that claims be "truthful and not misleading," and the agency confirms it has "no list of approved or accepted claims for cosmetics" — there's no pre-market review, no stamp of approval, no checklist a "dermatologist tested" bottle has to clear before it ships. Enforcement is after the fact: the FDA monitors the market and can issue warning letters when a cosmetic makes claims that cross into drug territory, and the Federal Trade Commission separately polices whether the advertising itself is deceptive.
That FTC role matters more than it sounds. Its December 2022 guidance on health-related product claims is explicit that "advertisers must have a reasonable basis for their product claims before disseminating an ad" — the substantiation duty sits with the company making the claim, not with a regulator checking it beforehand. Nobody polices the label at the register; the FTC's leverage kicks in only if a challenge or complaint follows.
What does "clinically tested" or "clinically proven" actually require?
More than "dermatologist tested," but still self-reported. The FTC guidance draws a real distinction: a claim like "clinically tested" implies "not just that the ingredient was tested, but also that the test results prove a benefit" — so a brand using that phrase is on the hook for a specific outcome, not just a lab session. The agency is equally specific that the bar scales with the language: "marketers of health-related products must have at least the level of support that they claim to have," so a product marketed as "clinically proven" needs evidence at that certainty level, not a softer one.
The guidance also flags the workaround brands lean on instead. Words like "may" or "helps" are, in the FTC's own phrasing, "unlikely to sufficiently convey the limitations of the science" when the underlying research is thin — which is exactly why so many bottles hedge with "helps reduce the appearance of" rather than committing to a number. None of this is checked by a regulator before the product ships; it's the standard a company is supposed to meet if anyone ever asks it to show its work.
So what should you actually look for on a label?
Specificity beats adjectives. "Dermatologist tested" tells you a dermatologist was involved somewhere, not what they measured or found — treat it the same as "hypoallergenic": a marketing signal, not a result. A brand that instead names the test, the sample size, or a specific measured outcome ("reduced visible redness in a 4-week consumer test on 32 subjects," attributed to the brand's own study) has at least given you something to evaluate, even though it's still the brand's own account and not independent verification.
The practical move is the same one that works for a price tag: check who's making the claim and what specifically they're claiming, not just the adjective on the front of the bottle. A named test with a named sample size is worth more than three unearned-sounding words in bold type, even when both appear on products that cost the same amount at the register.
| Label phrase | What it legally requires | What it doesn't tell you |
|---|---|---|
| Hypoallergenic | Nothing filed with the FDA; no federal definition exists | Whether anyone tested for allergic reactions at all |
| Dermatologist tested | No standard test, no required disclosure of results | What was measured, on how many people, or what counted as a pass |
| Clinically tested | FTC substantiation duty attaches if challenged — the brand must be able to show a proven benefit | Whether that evidence has ever actually been checked by a regulator |
| Clinically proven | Same FTC duty, at a higher evidentiary bar tied to the word "proven" | The size, design, or independence of the underlying study |
None of this means every "dermatologist tested" product is worthless, and it isn't a claim of misconduct against any brand — the phrase is legal to use precisely because the law leaves it undefined. It does mean the words on the front of the bottle aren't doing the verification work they sound like they're doing. That check is still yours to run.
For a related value perspective, read How to tell if that “was” price is actually real.